ImportRefusal LogoImportRefusal

Fine Foods & Pharmaceuticals N.T.M. S.P.A.

⚠️ Moderate Risk

FEI: 3013070993 • Verdellino, Bergamo • ITALY

FEI

FEI Number

3013070993

📍

Location

Verdellino, Bergamo

🇮🇹

Country

ITALY
🏢

Address

Via Berlino 39, , Verdellino, Bergamo, Italy

Moderate Risk

FDA Import Risk Assessment

41.5
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

4
Total Refusals
5
Unique Violations
6/13/2025
Latest Refusal
8/31/2004
Earliest Refusal

Score Breakdown

Violation Severity
47.1×40%
Refusal Volume
25.9×30%
Recency
73.6×20%
Frequency
1.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

23002×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

4822×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

3281×

USUAL NAME

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

751×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
6/13/2025
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
482NUTRIT LBL
Division of Southeast Imports (DSEI)
6/13/2025
54YCY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
2300DIETARYLBL
482NUTRIT LBL
Division of Southeast Imports (DSEI)
2/25/2014
63XCY99DIAGOSTIC AID (DRUGS) N.E.C.
75UNAPPROVED
Cincinnati District Office (CIN-DO)
8/31/2004
30AYY99FRUIT BEVERAGE BASE, N.E.C.
328USUAL NAME
473LABELING
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Fine Foods & Pharmaceuticals N.T.M. S.P.A.'s FDA import refusal history?

Fine Foods & Pharmaceuticals N.T.M. S.P.A. (FEI: 3013070993) has 4 FDA import refusal record(s) in our database, spanning from 8/31/2004 to 6/13/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Fine Foods & Pharmaceuticals N.T.M. S.P.A.'s FEI number is 3013070993.

What types of violations has Fine Foods & Pharmaceuticals N.T.M. S.P.A. received?

Fine Foods & Pharmaceuticals N.T.M. S.P.A. has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Fine Foods & Pharmaceuticals N.T.M. S.P.A. come from?

All FDA import refusal data for Fine Foods & Pharmaceuticals N.T.M. S.P.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.